16 Comparison of vitamin D dosing regimens in non-obese and obese patients with low vitamin D levels

Monday, October 22, 2012
Westin Diplomat Resort
Bryan L. Schuessler, Pharm.D., M.S.1, Janelle F. Ruisinger, PharmD2, Dennis W. Grauer, PhD3, Patrick M. Moriarty, MD2 and James M. Backes, PharmD4
1The University of Kansas Hospital, Kansas City, KS
2University of Kansas Atherosclerosis and LDL-Apheresis Center, Kansas City, KS
3University of Kansas Medical Center, Kansas City, KS
4Mail Stop 4047, University of Kansas Atherosclerosis and LDL-Apheresis Center, Kansas City, KS

Purpose: Obese populations have demonstrated lower levels of 25-hydroxyvitamin D compared to non-obese subjects, yet it is unclear whether obese patients require greater amounts of vitamin D supplementation to achieve adequate repletion. The objective of this study was to compare the response to vitamin D supplementation between obese and non-obese patients based on 25-hydroxyvitamin D levels.

Methods: Patients treated in a lipid specialty clinic who were over 18 years of age, had a documented low baseline 25-hydroxyvitamin D level, received vitamin D supplementation, and had a documented follow-up 25-hydroxyvitamin D level from January 1, 2007 to December 31, 2011 were included. Key exclusion criteria included history of osteoporosis, organ transplant/dysfunction, thyroid disorder, gastric bypass, hyperphosphatemia, and chronic kidney disease. Patients with a body mass index (BMI) >30 kg/m2 were classified as obese, whereas those <30 kg/m2 were considered non-obese. 

Results: Data from 66 non-obese and 92 obese patients were analyzed. The groups differed significantly in regards to mean BMI (26.5 kg/m2 vs. 34 kg/m2, p<0.001), and those considered obese had higher rates of hypertension, diabetes, and metabolic syndrome (p<0.001). Mean baseline 25-hydroxyvitamin D levels were similar in both groups (20 ng/ml vs.18 ng/ml; p=0.094). Groups were prescribed similar mean initial bolus (loading) dosing (48,400 units/day vs 51,680 units/day; p=0.405) and maintenance dosing (2707 units/day vs. 3181 units/day; p=0.284). Duration of bolus dosing (10 days vs. 11 days; p=0.236) and maintenance dosing (188 days vs. 168 days; p=0.290) was similar in both groups, as was mean follow up 25-hydroxyvitamin D levels after supplementation (40.4 ng/ml vs. 38 ng/ml; p=0.290).

Conclusion: Non-obese and obese patients had similar rates of vitamin D deficiency and did not require significantly different amounts or duration of vitamin D supplementation to achieve repletion. More information is required before modifying vitamin D supplementation regimens based on patient weight.